[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Atricure Inc (ATRC)

Atricure Inc (ATRC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,458,461
  • Shares Outstanding, K 50,641
  • Annual Sales, $ 534,530 K
  • Annual Income, $ -11,450 K
  • EBIT $ -3 M
  • EBITDA $ 18 M
  • 60-Month Beta 1.26
  • Price/Sales 2.57
  • Price/Cash Flow 92.01
  • Price/Book 2.97

Options Overview Details

View History
  • Implied Volatility 74.37% (+5.73%)
  • Historical Volatility 43.03%
  • IV Percentile 41%
  • IV Rank 48.70%
  • IV High 114.53% on 03/30/26
  • IV Low 36.25% on 08/18/25
  • Expected Move (DTE 27) 1.87 (6.49%)
  • Put/Call Vol Ratio 6.00
  • Today's Volume 28
  • Volume Avg (30-Day) 18
  • Put/Call OI Ratio 5.38
  • Today's Open Interest 2,595
  • Open Int (30-Day) 2,522
  • Expected Range 26.93 to 30.67

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $0.03
  • Number of Estimates 2
  • High Estimate $0.03
  • Low Estimate $0.02
  • Prior Year $-0.02
  • Growth Rate Est. (year over year) +250.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
25.36 +13.56%
on 06/02/26
29.31 -1.74%
on 05/21/26
+0.32 (+1.12%)
since 05/18/26
3-Month
25.36 +13.56%
on 06/02/26
30.67 -6.10%
on 03/25/26
-0.05 (-0.17%)
since 03/18/26
52-Week
25.36 +13.56%
on 06/02/26
43.18 -33.30%
on 01/08/26
-2.81 (-8.89%)
since 06/18/25

Most Recent Stories

More News
AtriCure to Participate in the Goldman Sachs 47th Annual Global Health Care Conference

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative...

ATRC : 28.80 (+6.19%)
AtriCure Conference: New Devices, EnCompass Drive 2026 Growth Outlook

AtriCure (NASDAQ:ATRC) executives said the company’s 2026 revenue outlook is being supported by recent and upcoming product launches, continued adoption of its EnCompass ablation platform and expanding...

ATRC : 28.80 (+6.19%)
AtriCure Reports First Quarter 2026 Financial Results

First Quarter 2026 worldwide revenue of $141.2 million, an increase of 14.3% year over year First Quarter 2026 profitability improved, with net income of $0.1 million and adjusted EBITDA...

ATRC : 28.80 (+6.19%)
AtriCure to Participate in the 2026 Bank of America Securities Health Care Conference

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative...

ATRC : 28.80 (+6.19%)
AtriCure to Announce First Quarter 2026 Financial Results

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative...

ATRC : 28.80 (+6.19%)
AtriCure to Participate in the Citizens Life Sciences Conference

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative...

ATRC : 28.80 (+6.19%)
AtriCure: Q4 Earnings Snapshot

AtriCure: Q4 Earnings Snapshot

ATRC : 28.80 (+6.19%)
AtriCure Reports Fourth Quarter 2025 and Full Year 2025 Financial Results

Fourth Quarter 2025 worldwide revenue of $140.5 million – an increase of 13.1% year over year Fourth Quarter 2025 net income of $1.8 million and positive adjusted EBITDA of $19.9 million...

ATRC : 28.80 (+6.19%)
AtriCure to Announce Fourth Quarter and Full Year 2025 Financial Results

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative...

ATRC : 28.80 (+6.19%)
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2025, Provides Financial Outlook for 2026

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative...

ATRC : 28.80 (+6.19%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed above 50%. The market is indicating support for a bullish trend.

See More Share

Business Summary

AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as...

See More

Key Turning Points

3rd Resistance Point 31.02
2nd Resistance Point 30.02
1st Resistance Point 29.41
Last Price 28.80
1st Support Level 27.81
2nd Support Level 26.81
3rd Support Level 26.20

See More

52-Week High 43.18
Fibonacci 61.8% 36.37
Fibonacci 50% 34.27
Fibonacci 38.2% 32.17
Last Price 28.80
52-Week Low 25.36

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.